AAAAAA
Results:
1-22
|
Results: 22
Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vegote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, INT J GYN C, 11, 2001, pp. 20-20
Authors:
Valentin, L
Hagen, B
Tingulstad, S
Eik-Nes, S
Citation: L. Valentin et al., Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective crossvalidation, ULTRASOUN O, 18(4), 2001, pp. 357-365
Authors:
Moller, P
Heimdal, K
Apold, J
Fredriksen, A
Borg, A
Hovig, E
Hagen, A
Hagen, B
Pedersen, JC
Maehle, L
Citation: P. Moller et al., Genetic epidemiology of BRCA1 mutations in Norway, EUR J CANC, 37(18), 2001, pp. 2428-2434
Authors:
Oswald, WD
Hagen, B
Rupprecht, R
Citation: Wd. Oswald et al., Non-drug therapy and prevention of Alzheimer disease, Z GERON GER, 34(2), 2001, pp. 116-121
Coupling strength between localized Ca2+ transients and K+ channels is regulated by protein kinase C
Authors:
Bayguinov, O
Hagen, B
Kenyon, JL
Sanders, KM
Citation: O. Bayguinov et al., Coupling strength between localized Ca2+ transients and K+ channels is regulated by protein kinase C, AM J P-CELL, 281(5), 2001, pp. C1512-C1523
Authors:
Bayguinov, O
Hagen, B
Sanders, KM
Citation: O. Bayguinov et al., Muscarinic stimulation increases basal Ca2+ and inhibits spontaneous Ca2+ transients in murine colonic myocytes, AM J P-CELL, 280(3), 2001, pp. C689-C700
Authors:
Onsrud, M
Hagen, B
Strickert, T
Citation: M. Onsrud et al., 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri, GYNECOL ONC, 82(1), 2001, pp. 167-171
Authors:
Anzini, M
Cappelli, A
Vomero, S
Seeber, M
Menziani, MC
Langer, T
Hagen, B
Manzoni, C
Bourguignon, JJ
Citation: M. Anzini et al., Mapping and fitting the peripheral benzodiazepine receptor binding site bycarboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling, J MED CHEM, 44(8), 2001, pp. 1134-1150
Authors:
Hagen, B
Shepherd, JH
Jacobs, IJ
Citation: B. Hagen et al., Parametrial resection for invasive cervical cancer, INT J GYN C, 10(1), 2000, pp. 1-6
Authors:
Demeyer, D
Raemaekers, M
Rizzo, A
Holck, A
De Smedt, A
ten Brink, B
Hagen, B
Montel, C
Zanardi, E
Murbrekk, E
Leroy, F
Vandendriessche, F
Lorentsen, K
Venema, K
Sunesen, L
Stahnke, L
De Vuyst, L
Talon, R
Chizzolini, R
Eerola, S
Citation: D. Demeyer et al., Control of bioflavour and safety in fermented sausages: first results of aEuropean project, FOOD RES IN, 33(3-4), 2000, pp. 171-180
Authors:
Hagen, B
Citation: B. Hagen, To the 60th birthday of Wolf D. Oswald, Z GERON GER, 33(2), 2000, pp. 143-144
Authors:
Trope, C
Kaern, J
Hogberg, T
Abeler, V
Hagen, B
Kristensen, G
Onsrud, M
Pettersen, E
Rosenberg, P
Sandvei, R
Sundfor, K
Vergote, I
Citation: C. Trope et al., Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument, ANN ONCOL, 11(3), 2000, pp. 281-288
Authors:
Bayguinov, O
Hagen, B
Bonev, AD
Nelson, MT
Sanders, KM
Citation: O. Bayguinov et al., Intracellular calcium events activated by ATP in murine colonic myocytes, AM J P-CELL, 279(1), 2000, pp. C126-C135
Authors:
Beauchaine, TP
Gartner, J
Hagen, B
Citation: Tp. Beauchaine et al., Comorbid depression and heart rate variability as predictors of aggressiveand hyperactive symptom responsiveness during inpatient treatment of conduct-disordered, ADHD boys, AGGR BEHAV, 26(6), 2000, pp. 425-441
Authors:
Hogdall, EVS
Hogdall, CK
Tingulstad, S
Hagen, B
Nustad, K
Xu, FJ
Bast, RC
Jacobs, IJ
Citation: Evs. Hogdall et al., Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass, INT J CANC, 89(6), 2000, pp. 519-523
Authors:
Hagen, B
Skjeldestad, FE
Halvorsen, T
Strickert, T
Tingulstad, S
Lorenz, E
Onsrud, M
Citation: B. Hagen et al., Primary treatment of cervical carcinoma - Ten years experience from one Norwegian health region, ACT OBST SC, 79(12), 2000, pp. 1093-1099
Authors:
Lorenz, E
Hagen, B
Himmelmann, A
Kjorstadt, K
Onsrud, M
Tingulstad, S
Gundersen, G
Citation: E. Lorenz et al., A phase II study of biweekly administration of paclitaxel in patients withrecurrent epithelial ovarian cancer, INT J GYN C, 9(5), 1999, pp. 373-376
Authors:
Hagen, B
Onsrud, M
Dale, O
Citation: B. Hagen et al., A pharmacokinetic and clinical evaluation of thio-TEPA in combination withcisplatin as first-line chemotherapy for advanced epithelial ovarian carcinoma, INT J GYN C, 9(2), 1999, pp. 110-116
Authors:
Dale, O
Thommesen, L
Mortensen, B
Hagen, B
Citation: O. Dale et al., Gender aspects of liver slice incubations with N,N,N-triethylene-thiophosphamide (thio-TEPA) in rats and mice, PHARM TOX, 84(3), 1999, pp. 122-124
Authors:
Tingulstad, S
Hagen, B
Skjeldestad, FE
Halvorsen, T
Nustad, K
Onsrud, M
Citation: S. Tingulstad et al., The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals, OBSTET GYN, 93(3), 1999, pp. 448-452
Authors:
Bayguinov, O
Keef, KD
Hagen, B
Sanders, KM
Citation: O. Bayguinov et al., Parallel pathways mediate inhibitory effects of vasoactive intestinal polypeptide and nitric oxide in canine fundus, BR J PHARM, 126(7), 1999, pp. 1543-1552
Authors:
Dorum, A
Heimdal, K
Lovslett, K
Kristensen, G
Hansen, LJ
Sandvei, R
Schiefloe, A
Hagen, B
Himmelmann, A
Jerve, F
Shetelig, K
Fjaerestad, I
Trope, C
Moller, P
Citation: A. Dorum et al., Prospectively detected cancer in familial breast/ovarian cancer screening, ACT OBST SC, 78(10), 1999, pp. 906-911
Risultati:
1-22
|